3rd Quarter - Report

SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES for SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES

Firm
Client
Income
—
Expenses
$370,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

Monitored the Build Back Better Act (H.R. 5376) for implications on international trade and supply chain issues.

LobbyistCovered position, as disclosed
JOE AUGUSTUS —
CHRISTINE HEWITT LANZA —
DANIEL TROPE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 5376 (117th)

Tobacco TOB

Outreach and monitoring related to the tobacco industry. Congressional outreach and monitoring related to federal excise taxes, including: -H.R. 3407 / S. 411, MOMMA's Act. -H.R. 2786 / S. 1314, Tobacco Tax Equity Act. -H.R. 5376, Build Back Better Act. Congressional outreach and monitoring related to Congressional priorities on tobacco products and flavorings. Congressional outreach and monitoring related to H.R. 4356 / S. 2599, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations, FY2022. Monitored the following: -FDA operations and tobacco policy on the following issues: proposed flavor restrictions, online sales bans, federal excise taxes, and tobacco product user fees. -Implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). -Federal and legislative action related to the marketing and advertising of tobacco products. -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. -FDA's Proposed Rule, Tobacco Product Standard for Characterizing Flavors in Cigars (RIN 0910-AI28) -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) -FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065)

LobbyistCovered position, as disclosed
JOE AUGUSTUS —
CHRIS HOWARD —
CHRISTINE HEWITT LANZA —
DANIEL TROPE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 5376 (117th), H.R. 3407 (117th), S. 2599 (117th), S. 1314 (117th), H.R. 2786 (117th), H.R. 4356 (117th), S. 411 (117th)

Health Issues HCR

Outreach and monitoring related to the tobacco industry. Congressional outreach and monitoring related to federal excise taxes, including: -H.R. 3407 / S. 411, MOMMA's Act. -H.R. 2786 / S. 1314, Tobacco Tax Equity Act. -H.R. 5376, Build Back Better Act. Congressional outreach and monitoring related to Congressional priorities on tobacco products and flavorings. Congressional outreach and monitoring related to H.R. 4356 / S. 2599, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations, FY2022. Monitored the following: -FDA operations and tobacco policy on the following issues: proposed flavor restrictions, online sales bans, federal excise taxes, and tobacco product user fees. -Implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). -Federal and legislative action related to the marketing and advertising of tobacco products. -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. -FDA's Proposed Rule, Tobacco Product Standard for Characterizing Flavors in Cigars (RIN 0910-AI28) -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) -FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065)

LobbyistCovered position, as disclosed
JOE AUGUSTUS —
CHRIS HOWARD —
CHRISTINE HEWITT LANZA —
DANIEL TROPE —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 5376 (117th), H.R. 2786 (117th), S. 411 (117th), S. 1314 (117th), H.R. 3407 (117th), S. 2599 (117th), H.R. 4356 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.